Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
  1. 4 Grant or award See Remarks acquired 20,080 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale See Remarks sold 896 shares at $10.38 ($9,300)
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale See Remarks sold 1,224 shares at $13.05 ($15,978)
  7. 4 Open-market sale See Remarks sold 4,588 shares at $13.05 ($59,892)
  8. 4 Open-market sale CEO sold 11,091 shares at $13.05 ($144,782)
  9. 4 Open-market sale General Counsel sold 1,175 shares at $13.05 ($15,338)
  10. 4 Open-market sale See Remarks sold 3,080 shares at $16.63 ($51,205)
  11. 4 Open-market sale See Remarks sold 917 shares at $16.63 ($15,245)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale See Remarks sold 1,064 shares at $18.50 ($19,688)
  17. 4 Open-market sale See Remarks sold 3,989 shares at $18.50 ($73,812)
  18. 4 Open-market sale CEO sold 9,650 shares at $18.50 ($178,564)
  19. 4 Open-market sale General Counsel sold 1,027 shares at $18.50 ($19,004)
  20. 4 Open-market sale See Remarks sold 812 shares at $23.02 ($18,688)

Page 6 of 21 · 406 filings